Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Effects of a New Creatine Formulation (CreaSafe®) on Kidney Function, Skeletal Muscles, and Cardiopulmonary Function in Athletes and Patients With COPD

NCT06991426 is registered in ClinicalTrials.gov with Federal University of São Paulo as lead sponsor.

NCT NCT06991426
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06991426 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Effects of a New Creatine Formulation (CreaSafe®) on Kidney Function, Skeletal Muscles, and Cardiopulmonary Function in Athletes and Patients With COPD
Lead sponsor
Federal University of São Paulo
Phase
Phase 4
Overall status
Not yet recruiting
Start date
July 31, 2025
Completion date
October 31, 2025
Enrollment
140 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

athletes, copd